Marker for the detection of pancreatic cancer

With glycoprotein C4BPA or PIGR as markers for detecting pancreatic cancer, pancreatic cancer can be determined specifically distinguishes between chronic pancreatitis patients and healthy individuals. In addition, it is possible to monitor the status of the prognosis of pancreatic cancer patients after surgery. Furthermore, other pancreatic cancer markers, for example, by using it in conjunction with a CA19-9, can be determined more specifically by distinguishing chronic pancreatitis patients and healthy individuals.